PRO: intraperitoneal chemotherapy should be standard-of-care for epithelial ovarian cancer patients

被引：0

作者：

Markman, Maurie ^{[1
]}

机构：

[1] Eastern Reg Med Ctr, Canc Treatment Ctr Amer, Philadelphia, PA USA

来源：

13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY | 2010年

关键词：

GYNECOLOGIC-ONCOLOGY-GROUP; INTRAVENOUS CISPLATIN; PHASE-I; CARCINOMA; PHARMACOKINETICS; PACLITAXEL; SURVIVAL; THERAPY; TRIAL;

D O I：

暂无

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The results of several multi-center cooperative group phase 3 clinical trials have revealed the favorable impact on overall survival associated with the intraperioneal administration of cisplatin-based primary chemotherapy in the management of small volume residual advanced ovarian cancer. These data strongly support the conclusion that regional therapy should be considered a standard-of-care option in this clinical setting. Future research efforts should focus both on decreaseing the toxicity associated with this novel treatment strategy (e.g., substituting carboplatin for cisplatin) and improving efficacy (e.g., exploration of hyperthermic intraperitoneal drug delivery).

引用

页码：45 / 48

页数：4

共 50 条

[41] A Modified Intraperitoneal Chemotherapy Regimen for Ovarian Cancer: Technique and Treatment Outcomes [J].

Kim, Ji Hyun ;

Ha, Hyeong In ;

Kim, Min Hae ;

Han, Mi Ra ;

Park, Sang-Yoon ;

Lim, Myong Cheol .

CANCERS, 2021, 13 (19)

[42] Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer [J].

Lan, Chunyan ;

Li, Yanfang ;

Liu, Jihong .

GYNECOLOGIC ONCOLOGY, 2009, 114 (01) :42-47

[43] Intraoperative Hyperthermic intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer [J].

Oseledchyk, Anton ;

Zivanovic, Oliver .

ONCOLOGY-NEW YORK, 2015, 29 (09) :695-+

[44] Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer [J].

Lee, Jessica ;

Curtin, John P. ;

Muggia, Franco M. ;

Pothuri, Bhavana ;

Boyd, Leslie R. ;

Blank, Stephanie V. .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (01) :55-63

[45] Intraperitoneal chemotherapy in the management of patients with advanced epithelial ovarian cancer: a critical review of the literature [J].

Gadducci, A. ;

Conte, P. F. .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (05) :943-953

[46] Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer [J].

van Driel, W. J. ;

Koole, S. N. ;

Sikorska, K. ;

van Leeuwen, J. H. Schagen ;

Schreuder, H. W. R. ;

Hermans, R. H. M. ;

de Hingh, I. H. J. T. ;

van der Velden, J. ;

Arts, H. J. ;

Massuger, L. F. A. G. ;

Aalbers, A. G. J. ;

Verwaal, V. J. ;

Kieffer, J. M. ;

Van de Vijver, K. K. ;

van Tinteren, H. ;

Aaronson, N. K. ;

Sonke, G. S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (03) :230-240

[47] Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer [J].

Fujiwara, Keiichi ;

Nagao, Shoji ;

Aotani, Eriko ;

Hasegawa, Kosei .

EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (13) :1797-1806

[48] Update on the management and the role of intraperitoneal chemotherapy for ovarian cancer [J].

Teo, Melissa C. C. .

CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2014, 26 (01) :3-8

[49] An Update on the Use of Intraperitoneal Chemotherapy in the Management of Ovarian Cancer [J].

Markman, Maurie .

CANCER JOURNAL, 2009, 15 (02) :105-109

[50] Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono? [J].

Spiliotis, John .

ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (24)

← 1 2 3 4 5 →